These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9921868)

  • 21. [Dilution effect of serum creatine phosphokinase and myoglobin in progressive muscular dystrophy].
    Ohno T; Morikawa I; Suzuki T; Iwasa M; Mouri A
    No To Hattatsu; 1986 Sep; 18(5):418-20. PubMed ID: 3756026
    [No Abstract]   [Full Text] [Related]  

  • 22. Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy.
    Andersen SP; Sveen ML; Hansen RS; Madsen KL; Hansen JB; Madsen M; Vissing J
    Muscle Nerve; 2013 Dec; 48(6):897-901. PubMed ID: 23512655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal rhabdomyolysis as a presentation of muscular dystrophy.
    Breningstall GN; Grover WD; Barbera S; Marks HG
    Neurology; 1988 Aug; 38(8):1271-2. PubMed ID: 3399077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.
    Düzgün N; Ayaşlioğlu E; Tutkak H; Aydintuğ OT
    Rheumatol Int; 2005 Jan; 25(1):1-5. PubMed ID: 14600787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of Becker muscular dystrophy and massive myoglobinuria with minimal renal manifestations.
    Shoji T; Nishikawa Y; Saito N; Hayashi T; Togawa M; Okada N; Tsubakihara Y
    Nephrol Dial Transplant; 1998 Mar; 13(3):759-60. PubMed ID: 9550662
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum ATP: creatine phosphotransferase activity in guinea-pigs with experimental muscular dystrophy.
    Bird JW; Carabello F
    Nature; 1966 Apr; 210(5031):95-6. PubMed ID: 5957631
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of determination of creatine phosphokinase activity in blood serum for detection of carriers of prograssive muscular dystrophy].
    Hetnarska L
    Neurol Neurochir Pol; 1967; 1(5):583-6. PubMed ID: 6064455
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
    Vainzof M; Zatz M; Otto PA
    Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathogenesis of pulmonary thrombosis in Duchenne muscular dystrophy; a consideration from changes in serum CK and LDH levels].
    Nakayama T; Saito Y; Uchiyama T; Yatabe K; Kawai M
    Rinsho Shinkeigaku; 2000 Jan; 40(1):55-8. PubMed ID: 10825803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 32. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease].
    Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M
    Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum levels of vascular endothelial growth factor elevated in patients with muscular dystrophy.
    Saito T; Yamamoto Y; Matsumura T; Fujimura H; Shinno S
    Brain Dev; 2009 Sep; 31(8):612-7. PubMed ID: 18980821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1 receptor antagonist in arthritis and arthritis models.
    Thompson RC
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S169. PubMed ID: 8324943
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant hyperthermia-like episode in Becker muscular dystrophy.
    Kleopa KA; Rosenberg H; Heiman-Patterson T
    Anesthesiology; 2000 Dec; 93(6):1535-7. PubMed ID: 11149452
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human lymphocyte capping in Duchenne muscular dystrophy.
    Horenstein AL; Emery AE
    Neurology; 1980 Dec; 30(12):1330-2. PubMed ID: 7192813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.